Skip to content

Novasight Hybrid Intravascular Ultrasound and Optical Coherence Tomography System (IVUS OCT)

Novasight Hybrid Intravascular Ultrasound and Optical Coherence Tomography System (IVUS OCT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03484975
Enrollment
23
Registered
2018-04-02
Start date
2018-08-01
Completion date
2021-08-18
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Stable Angina

Brief summary

Collection of coronary images with a hybrid IVUS OCT system.

Detailed description

A prospective observational imaging study in patients undergoing coronary angiography and intravascular imaging for either diagnostic purposes or for PCI following a presentation with either stable angina or an acute coronary syndrome.

Interventions

Collect coronary images with a hybrid IVUS OCT system.

Sponsors

Conavi
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient is at least 18 years old. 2. Patients arriving for coronary angiography or possible PCI with stable angina or acute coronary syndrome (including unstable angina, NSTEMI or STEMI). 3. Patients with STEMI may be undergoing subsequent staged PCI to additional coronary stenoses after the index STEMI event has been successful treated with primary PCI. 4. Vascular access of at least 6F. 5. Patient provides informed, written consent for participation in the study. 6. A target lesion is present in a suitable artery for intravascular imaging.

Exclusion criteria

1. Angiographic evidence of severe calcification 2. Marked tortuosity that precludes imaging of a target coronary artery. 3. GFR (Glomerular filtration rate) \<35 mL/min. 4. Patients in cardiogenic shock. 5. Women of child bearing potential, in whom pregnancy cannot be excluded. 6. Patients of age \< 18 years old. 7. Patients with an allergy to contrast. 8. Patients unable to grant informed, written consent for participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Collection of the first human coronary images with the hybrid IVUS OCT technologyClinical Report Forms (capturing image analysis) will be completed for each case no later then 72 hours after the procedure.The hybrid IVUS OCT system permits simultaneous and co-registered acquisition of IVUS and OCT coronary images. IVUS and/or OCT series can be recorded up to 10 cm of the vessel length or up to 20 s of imaging. The physician will review 10 frames and evaluate independently IVUS images, OCT images and the combined IVUS-OCT images for the ability to identify and characterize coronary lesion categories: lipid plaque, calcified plaque, fibrous plaque, thin fibrous cap, positive remodelling and plaque burden. Results, for each frame and imaging modality, of lesion assessment will be tabulated as: a) non-assessable, b) assessable and present, c) assessable and absent. The Clinical Report Form captures tabulated sections for each imaging modality and specific frame selected for lesion evaluation. Results will be presented qualitatively and quantitative as categorical calculations. Image interpretation will be performed independently and blinded to clinical and angiographic information.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026